Breaking News on Pharmaceutical Technology

Headlines > Processing & QC

Accelrys moves into Pharma QA/QC with VelQuest acquisition

05-Jan-2012 - R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.

US FDA's 2011 guidance documents round-up

05-Jan-2012 - The US Food and Drug Administration (FDA) will soon start asking drugmakers to play a greater role in guideline development . Before that process begins in-Pharmatechnologist.com takes a look at the documents published by the agency in 2011.

EC discusses ‘equivalence assessments’ for APIs shipped to EU

03-Jan-2012 - The European Commission (EC) has set out its plans for ‘equivalence assessments’ for manufacturers in countries seeking to export APIs to Europe.

India posts draft guidance on stability data for clinical trials

02-Jan-2012 - India has released draft guidance on stability data needed to support approval of Phase I to III clinical trials.

Pall to buy ForteBio to build biopharma biz

22-Dec-2011 - Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.

Ranbaxy inks consent decree & prepares for $500m penalty

21-Dec-2011 - Ranbaxy has signed a consent decree with the US FDA and set aside $500m for penalty payments to settle its longstanding dispute.

SE Asia likely source of fake anti-malarials in Africa; study

20-Dec-2011 - Counterfeit anti-malarials containing the Viagra API were probably manufactured in Southeast Asia, researchers found.

Final rule adds manufacturing delay reporting requirements

19-Dec-2011 - Manufacturers of certain critical drugs must report production interruptions to the FDA under a new interim final rule.

GE wont say if turnkey bioplant partnership will cut prices for emerging nations

19-Dec-2011 - GE Healthcare wont say if its new turnkey biologics plant development service will offer Governments in emerging nations discounted rates.

Drug quality treaty needed to raise standards, academics say

15-Dec-2011 - A treaty on medicine quality is needed to fix the major public health problem of substandard drugs, according to academics.

GE and M+W team on plant and tech biologics production solution

14-Dec-2011 - GE Healthcare and M+W Group aim to capture a share of the rapidly expanding global biologics market with a new plant and manufacturing tech partnership.

EMA calls for Vistide recall over Ben Venue contamination fears

14-Dec-2011 - The EMA has recommended recalling a batch of Gilead’s Vistide manufactured by Ben Venue over particle contamination concerns.

ADC Bio wins development grant for new ADC production tech

13-Dec-2011 - ADC Biotechnology (ADC Bio) has secured a development grant for a new antibody drug conjugate (ADC) manufacturing technology that, it says, can make drug production cheaper.

Joint FDA-EMA inspection programme to launch in January 2012

13-Dec-2011 - The FDA and the EMA will begin sharing facility inspection data in their respective territories from January to make better use of resources and reduce drugmakers’ inspection burdens.

Mettler Toledo says new tech will speed up API fermentation

08-Dec-2011 - Mettler Toledo says its new dissolved oxygen (DO) measuring optical sensors can speed up the API production process and reduce maintenance costs.

Bosch lauds new extrusion and calendaring line’s API solubility benefits

07-Dec-2011 - Bosch Packaging Technology says melt extrusion is the answer to drug manufacturers’ active pharmaceutical ingredient (API) solubility questions.

Ethiopian quality control lab gains ISO testing accreditation

05-Dec-2011 - The Ethiopian national quality control laboratory has gained ISO accreditation to improve access to safe medicines.

US firm offering modular plant leases as alternative to CMOs

01-Dec-2011 - Biologics Modular is leasing its mobile production facilities to help clients make FDA regulated drugs without fixed plants.

ATMI launches large-volume bioreactor with GMP compliance in mind

01-Dec-2011 - Large volume production is a must for the cell therapy sector according to ATMI, which claims the latest addition to its single-use bioreactor range can help manufacturers overcome the GMP hurdles that hinder commercial scale-up.

Sepha sees growing demand for cost saving testing tech

01-Dec-2011 - The drug industry's need to improve product quality while reducing production costs is driving global demand for testing technologies according to Sepha.

News in brief

Ranbaxy forms pact with Teva to launch generic Lipitor in US

01-Dec-2011 - Ranbaxy has introduced generic Lipitor in the US after partnering with Teva and gaining FDA approval for manufacture at its US plant.

Virus catching filter helps Novo stop batch tests on live animals

30-Nov-2011 - Novo Nordisk has stopped using living animals in batch quality tests after developing a virus filtration tool for factor VII production.

FDA anti-adulteration efforts hindered by industry; GAO

28-Nov-2011 - Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.

News in brief

Pfizer gains 1st ISO 50001 energy accreditation at Ireland plant

24-Nov-2011 - A Pfizer Ireland plant has become the first in its network to achieve ISO accreditation for cutting CO2 emissions and energy use.

EMA recalling oncology drugs manufactured by Ben Venue

23-Nov-2011 - The EMA is recalling cancer drugs manufactured by CMO Ben Venue Laboratories after inspectors found quality shortcomings.

Sign up for your free newsletter

Supplier Webinars